Schmidt LE et al. |
Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients. |
2003 |
Transplantation |
pmid:12883193
|
Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Troppmann C et al. |
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. |
2003 |
Transplantation |
pmid:12883205
|
Therapondos G et al. |
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? |
2003 |
Transplantation |
pmid:12883220
|
Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Burroughs TE et al. |
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. |
2007 |
Transplantation |
pmid:17452891
|
Andrades KM et al. |
Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. |
2013 |
Transplantation |
pmid:23380869
|
Adams PS et al. |
Postoperative cardiac tamponade after kidney transplantation: a possible consequence of alemtuzumab-induced cytokine release syndrome. |
2013 |
Transplantation |
pmid:23380870
|
Ellis D et al. |
Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10532541
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Boleslawski E et al. |
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. |
2004 |
Transplantation |
pmid:15223897
|
Hostettler KE et al. |
Cyclosporine A mediates fibroproliferation through epithelial cells. |
2004 |
Transplantation |
pmid:15223908
|
Yang CW et al. |
Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. |
2003 |
Transplantation |
pmid:12544865
|
Molano RD et al. |
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. |
2003 |
Transplantation |
pmid:12811239
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Trancassini M et al. |
Microbiologic investigation on patients with cystic fibrosis subjected to bilateral lung transplantation. |
2001 |
Transplantation |
pmid:11707748
|
Waldman WJ et al. |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. |
2001 |
Transplantation |
pmid:11707749
|
Miroux C et al. |
In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function. |
2012 |
Transplantation |
pmid:22743548
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Woodle ES et al. |
FK506--reversal of humorally mediated cardiac allograft rejection in the presence of preformed anti-class I antibody. |
1993 |
Transplantation |
pmid:7504346
|
Jindal RM et al. |
Effect of deoxyspergualin on the endocrine function of the rat pancreas. |
1993 |
Transplantation |
pmid:7504347
|
Eberhard OK et al. |
How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation. |
1996 |
Transplantation |
pmid:8629294
|
Jeske HC et al. |
Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat. |
2003 |
Transplantation |
pmid:14557751
|
Millis JM et al. |
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. |
1996 |
Transplantation |
pmid:8629298
|
Gerlach UA et al. |
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation. |
2017 |
Transplantation |
pmid:27607529
|
de Sandes-Freitas TV et al. |
Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. |
2015 |
Transplantation |
pmid:25929604
|
Jain A et al. |
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. |
2001 |
Transplantation |
pmid:11579306
|
Sheiner PA et al. |
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. |
1997 |
Transplantation |
pmid:9355846
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
van Hooff JP |
Pneumocystis carinii pneumonia after renal transplantation. |
1997 |
Transplantation |
pmid:9158038
|
Conrotto D et al. |
Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease. |
2006 |
Transplantation |
pmid:17060865
|
Reding R et al. |
Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. |
1994 |
Transplantation |
pmid:7507272
|
Kitayama T et al. |
Facilitation of tacrolimus-induced heart-allograft acceptability by pretransplant host treatment with granulocyte colony-stimulating factor: interleukin-12-restricted suppression of intragraft monokine mRNA expression. |
2003 |
Transplantation |
pmid:12605126
|
Storb R et al. |
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. |
1993 |
Transplantation |
pmid:7692635
|
Cacciarelli TV et al. |
Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. |
1996 |
Transplantation |
pmid:8610416
|
Egidi MF and Gaber AO |
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. |
2003 |
Transplantation |
pmid:12605133
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Osowski CL et al. |
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients. |
1996 |
Transplantation |
pmid:8610430
|
Tabasco-Minguillan J et al. |
Insulin requirements after liver transplantation and FK-506 immunosuppression. |
1993 |
Transplantation |
pmid:7692637
|
Watanabe M et al. |
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. |
2013 |
Transplantation |
pmid:23860082
|
Burroughs TE et al. |
Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. |
2009 |
Transplantation |
pmid:19667939
|
Mittal SK et al. |
Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. |
2009 |
Transplantation |
pmid:19667950
|
Nobori S et al. |
Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. |
2006 |
Transplantation |
pmid:16421473
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Kung L and Halloran PF |
Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. |
2000 |
Transplantation |
pmid:10933159
|
Beatty PR et al. |
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. |
1998 |
Transplantation |
pmid:9603175
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement. |
2002 |
Transplantation |
pmid:12490779
|
Maes BD et al. |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. |
1999 |
Transplantation |
pmid:10589943
|
Gruber SA et al. |
Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. |
2000 |
Transplantation |
pmid:10933170
|
Shapiro R et al. |
Alopecia as a consequence of tacrolimus therapy. |
1998 |
Transplantation |
pmid:9603186
|
Shapiro AM et al. |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. |
2002 |
Transplantation |
pmid:12490784
|
Fernandez LA et al. |
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. |
1999 |
Transplantation |
pmid:10589951
|
Mehra MR et al. |
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. |
2002 |
Transplantation |
pmid:12490790
|
Aulagnon F et al. |
Diarrhea after kidney transplantation: a new look at a frequent symptom. |
2014 |
Transplantation |
pmid:25073040
|
Tokita D et al. |
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. |
2008 |
Transplantation |
pmid:18301333
|
Niioka T et al. |
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation. |
2012 |
Transplantation |
pmid:23073468
|
Gruessner RW and Sharp HL |
Living-related intestinal transplantation: first report of a standardized surgical technique. |
1997 |
Transplantation |
pmid:9415566
|
Ekberg H et al. |
The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. |
2009 |
Transplantation |
pmid:19424036
|
Guerville F et al. |
Transplantation with pathologic kidneys to improve the pool of donors: an example of shunt nephritis. |
2012 |
Transplantation |
pmid:22487813
|
Swinnen LJ et al. |
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. |
2008 |
Transplantation |
pmid:18645482
|
Wannhoff A et al. |
Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. |
2014 |
Transplantation |
pmid:25022236
|
Shapiro R et al. |
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. |
2008 |
Transplantation |
pmid:18431232
|
Sureshkumar KK and Chopra B |
In search of an optimal induction agent in kidney transplantation. |
2014 |
Transplantation |
pmid:24978038
|
Welberry Smith MP and Baker RJ |
The author's reply. |
2014 |
Transplantation |
pmid:24978039
|
Sommerer C et al. |
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients. |
2010 |
Transplantation |
pmid:20463649
|
Tan HP et al. |
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. |
2008 |
Transplantation |
pmid:19104412
|
Devlin J and Williams R |
Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group. |
1996 |
Transplantation |
pmid:8932266
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
de Fijter JW |
Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? |
2011 |
Transplantation |
pmid:21654351
|
Brunet M et al. |
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16495801
|
MacDonald AS |
Management strategies for nephrotoxicity. |
2000 |
Transplantation |
pmid:10910262
|
Reyes J et al. |
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. |
2000 |
Transplantation |
pmid:10910279
|
Fealy MJ et al. |
Association of down-regulation of cytokine activity with rat hind limb allograft survival. |
1995 |
Transplantation |
pmid:7539555
|
Higgins RM et al. |
Conversion from tacrolimus to cyclosporine in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. |
2000 |
Transplantation |
pmid:10836393
|
Taylor-Fishwick DA et al. |
Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use. |
1993 |
Transplantation |
pmid:7689258
|
Garton T |
Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1. |
2002 |
Transplantation |
pmid:12352898
|
Yamauchi A et al. |
Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. |
2002 |
Transplantation |
pmid:12352921
|
Borni-Duval C et al. |
Risk factors for BK virus infection in the era of therapeutic drug monitoring. |
2013 |
Transplantation |
pmid:23778568
|
Ekser B et al. |
Hepatic function after genetically engineered pig liver transplantation in baboons. |
2010 |
Transplantation |
pmid:20606605
|
van Boekel GA et al. |
Effect of mild diarrhea on tacrolimus exposure. |
2012 |
Transplantation |
pmid:22955188
|
Woodle ES et al. |
Liver transplantation in the first three months of life. |
1998 |
Transplantation |
pmid:9753340
|
Mourer JS et al. |
Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients. |
2012 |
Transplantation |
pmid:22955227
|
Radkowski M et al. |
Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9753352
|
Guasch A et al. |
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. |
2010 |
Transplantation |
pmid:20811320
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. |
2004 |
Transplantation |
pmid:14742989
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. |
2004 |
Transplantation |
pmid:14742990
|
Azzola A et al. |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. |
2004 |
Transplantation |
pmid:14742993
|
van Hooff JP et al. |
Tacrolimus and posttransplant diabetes mellitus in renal transplantation. |
2005 |
Transplantation |
pmid:15940032
|
Wang X et al. |
Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. |
2005 |
Transplantation |
pmid:15940043
|
Nankivell BJ et al. |
Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. |
2004 |
Transplantation |
pmid:15167607
|
Gillard P et al. |
Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. |
2014 |
Transplantation |
pmid:24770614
|
Bazerbachi F et al. |
Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results. |
2013 |
Transplantation |
pmid:23183776
|
Günther M et al. |
Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. |
2001 |
Transplantation |
pmid:11233913
|
Ekberg H et al. |
Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation. |
2011 |
Transplantation |
pmid:21562449
|
Rezeig MA et al. |
Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. |
1997 |
Transplantation |
pmid:9175820
|
Kuypers DR et al. |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. |
2006 |
Transplantation |
pmid:16794545
|
Hricik DE et al. |
Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2003 |
Transplantation |
pmid:14508357
|
Foster RD et al. |
Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. |
2003 |
Transplantation |
pmid:14508367
|
Talento A et al. |
A single administration of LFA-1 antibody confers prolonged allograft survival. |
1993 |
Transplantation |
pmid:7679531
|
Mor E et al. |
Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7513098
|